Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
3rd September 2008 MUNICH, Germany, September 3 /PRNewswire/ -- A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment
with prasugrel compared with clopidogrel significantly reduced the risk of
new...
San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research
28th August 2008 HAYWARD, California, August 28 /PRNewswire/ -- Guava Technologies, Inc. announced the commencement of an agreement with
Hudson Control Group to provide drug discovery researchers with an...
Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC
27th August 2008 CHAPEL-EN-LE-FRITH, England and MILPITAS, California, August 27 /PRNewswire/ -- Peakdale Molecular Ltd (CHAPEL-EN-LE-FRITH, UK) a leading
provider in specialist chemistry services to the...
Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA
27th August 2008 SAN DIEGO and INDIANAPOLIS, August 27 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company
(NYSE: LLY) in a conference call today provided context and...
Genmab Reaches Fifth Milestone in Ofatumumab Collaboration
21st August 2008 COPENHAGEN, August 21 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has reached the fifth milestone
for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with
GlaxoSmithKline...
Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
21st August 2008 TOKYO and INDIANAPOLIS, August 21 /PRNewswire/ -- A new, pre-specified analysis of the landmark Phase III head-to-head
TRITON-TIMI 38 study showed patients who took prasugrel for acute...
Bavarian Nordic Announces Partnership With National Cancer Institute in the US and Obtains Rights to a New Vaccine Candidate
13th August 2008 KVISTGARD, Denmark, August 13 /PRNewswire/ -- Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics has entered into a
scientific partnership with the National Cancer Institute (NCI) in the...
Bavarian Nordic Announces Partnership With National Cancer Institute in the US and Obtains Rights to a New Vaccine Candidate
13th August 2008 KVISTGARD, Denmark, August 13 /PRNewswire/ -- Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics has entered into a
scientific partnership with the National Cancer Institute (NCI) in the...
Banque Centrale Populaire Consolidates Activity Abroad With New Trade Finance Solutions From Misys
5th August 2008 LONDON, August 5 /PRNewswire/ -- Banque Centrale Populaire (BCP), one of the largest banks in Morocco, has
strengthened its trade finance offer to corporates with the new trade finance
solutions from...
GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine
22nd July 2008 ATLANTA and NANTES, France, July 22 /PRNewswire/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based,
biopharmaceutical company developing human vaccines for diseases caused by
HIV-1...
Comprehensive Care International and SHI Consulting Announce Partnership for Effective Integration of Research Into Clinical Planning and Design
21st July 2008 TORONTO, July 21 /PRNewswire/ -- Comprehensive Care International (CCI) and SHI
Consulting Inc. (SHI) outlined their vision to create a sustainable
operational advantage for hospitals worldwide....
Physicians Practice and Nevada Cancer Institute Partner to Improve Patient Care
15th July 2008 BALTIMORE, July 15 /PRNewswire/ -- Physicians and patients of community-based medical practices in Nevada
and SW Utah will benefit from a new partnership between Physicians
Practice(R), America's...
Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform
15th July 2008 REDWOOD CITY, California, July 15 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life
science researchers, and CHDI Foundation, Inc., a non-profit...
AMT Starts Collaboration With St. Jude Children's Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
15th July 2008 AMSTERDAM, The Netherlands, July 15 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, today announced the start of a collaboration
with...
Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology
3rd July 2008 BIOCITECH, France, July 3 /PRNewswire/ -- Cellectis SA today announced the signature of an agreement
with Regeneron Pharmaceuticals, Inc. over the use of Cellectis' patents
covering certain uses of...
The Institut de la Vision and Iris Pharma Join Forces to Strengthen the Bond Between the Private and Public Sectors, and Between Industry and Academic Research
3rd July 2008 NICE, France, July 3 /PRNewswire/ -- The Institut de la Vision, a research center exclusively dedicated to eye
diseases, has been the industry's benchmark on vision-related issues since
its opening...
Genmab Reaches Milestone in Ofatumumab Collaboration
30th June 2008 COPENHAGEN, June 30 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has reached a development
milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration
with...
Elsevier Announces Agreement With Portico
26th June 2008 AMSTERDAM, June 26 /PRNewswire/ -- Elsevier, a leading publisher of scientific, technical and medical (STM)
information, today announced an agreement with Portico, a not-for-profit
digital...
Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
25th June 2008 REHOVOT, Israel and JERSEY CITY, New Jersey, June 25 /PRNewswire/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG), announced today a
collaboration with the Rabin Medical Center in Israel to...
ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
18th June 2008 LEUVEN, Belgium, LUND, Sweden and BASEL, Switzerland, June 18 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and BioInvent
International AB (Nordic Exchange: BINV) announce that they have...
MSD Signs Partnership With BMJ Group
17th June 2008 BERLIN, June 17 /PRNewswire/ -- The pharmaceutical company MSD (known as Merck Sharp & Dohme Limited in
the UK and Merck & Co., Inc. in the US) and BMJ (British Medical Journal)
Group today announced...
AmVac AG Begins Research Cooperation With Bayer Research Laboratory Inaugurated in Catania
12th June 2008 ZUG, Switzerland and CATANIA, Italy, June 12 /PRNewswire/ -- AmVac AG, a Swiss biopharmaceutical company based in Zug, is
starting its first research cooperation program with Bayer Innovation GmbH...
Mentice Initiates Collaboration With Pieter Stella as Clinical Advisor
12th June 2008 GOTHENBURG, June 12 /PRNewswire/ -- Mentice, a leading developer of medical simulation solutions, today
announces collaboration with Dr. Pieter Stella as Clinical Advisor to
Mentice. Dr Stella will...
Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
11th June 2008 TOKYO and NEW DELHI, India, June 11 /PRNewswire/ -- Daiichi Sankyo Company, Limited (TSE: 4568.JP) ("Daiichi Sankyo"), one of
the largest pharmaceutical companies in Japan, and Ranbaxy...
Merck Serono Strengthens its Prescription Medicines Portfolio in Latin America
10th June 2008 GENEVA, Switzerland, June 10 /PRNewswire/ -- Merck Serono (NYSE: SRA), a division of Merck KGaA, Darmstadt, Germany,
announced today the signing of a distribution agreement with Bristol-Myers
Squibb...
Ingenuity Systems Announces Multi-Year Agreement With Boehringer Ingelheim
3rd June 2008 REDWOOD CITY, California, June 3 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life
science researchers, announced the signing of a four year agreement...
ThromboGenics and BioInvent Report Positive Phase I Results for Anti-PlGF Cancer Therapeutic TB-403
3rd June 2008 LEUVEN, Belgium and LUND, Sweden, June 3 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and co-development
partner BioInvent International AB (Nordic Exchange: BINV) today reported
that...
Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Würzburg, Germany
29th May 2008 AMSTERDAM, May 29 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announces today the clinical
development collaboration for its lead product ATIR(TM) with Dr. Stephan
Mielke and Professor...
World Gastroenterology Organisation and Danone launch Global Campaign to Improve Digestive Health
29th May 2008 LONDON, May 29 /PRNewswire/ -- Today, on the occasion of World Digestive Health Day (WDHD), the World
Gastroenterology Organisation (WGO) has launched a year-long campaign titled
'Optimum Health and...
AMT's Cooperative Research and Development Agreement with NIH to Boost Production Capacity
26th May 2008 AMSTERDAM, The Netherlands, May 26 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, today announced that it obtained a
Cooperative...
University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
9th May 2008 CLEVELAND, Illinois and ROTTERDAM, The Netherlands, May 9 /PRNewswire/ -- University Hospitals Case Medical Center and Cardialysis BV today
announced that the Companies have the intention to found...
NTT Europe Online and Sun Start-Up Essentials Help Deliver Glasses Direct to Customers
25th April 2008 LONDON, April 25 /PRNewswire/ -- Glasses Direct has signed up as a member and customer of the
hosting offer in the Sun Start-Up Essentials program in the UK. As part of
the program, the online...
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
24th April 2008 LAS VEGAS, April 24 /PRNewswire/ -- CardioVascular BioTherapeutics, Inc. (OTC Bulletin Board: CVBTE) has
entered into an agreement with Mr. Phillip Frey Jr. to form Cardio Derma
Clinical Partners...
SCHOTT Forms Pharmaceutical Joint Venture in India
24th April 2008 MAINZ, Germany and MUMBAI, India, April 24 /PRNewswire/ -- SCHOTT AG and KAISHA Manufacturers Private Ltd., an Indian company,
announce the formation of a joint venture, SCHOTT KAISHA Private Ltd....
ESBATech's Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
24th April 2008 ZURICH, Switzerland, April 24 /PRNewswire/ -- ESBATech AG, a leading developer of antibody fragment therapeutics, today
announced the initiation of Phase I clinical development of the company's
lead...
Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
22nd April 2008 AMSTERDAM, Netherlands and SANTA CLARA, California, April 22 /PRNewswire/ -- Agendia BV, a world leader in the rapidly evolving field of molecular
diagnostics, and Agilent Technologies, Inc. (NYSE:...
Global Med Technologies(R), Inc. and Cerner Announce Strategic Alliance
9th April 2008 DENVER, April 9 /PRNewswire/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an
international e-Health, medical information technology company, today
announced that its Wyndgate...
Health Unions React to NHS Pay Offer
8th April 2008 LONDON, April 8 /PRNewswire/ -- Health unions representing 200,000 healthcare scientists, health
visitors, speech and language therapists, clinical psychologists, chaplains,
mental health nurses,...
Shire and TAP Agree to Co-promote LIALDA(TM) (Mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis
26th March 2008 BASINGSTOKE, England and PHILADELPHIA, March 26 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announced today a co-promotion agreement with...
Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
18th March 2008 PLANO, Texas, March 18 /PRNewswire/ -- Perot Systems Corporation (NYSE: PER) and ChinaSoft International
(HK8216) today announced that they have agreed to cooperatively develop
mutually beneficial...
Misys and Allscripts Create a Leader in Healthcare Software
18th March 2008 LONDON, March 18 /PRNewswire/ -- In a video interview Mike Lawrie, CEO Misys, and Glen Tullman, CEO
Allscripts, talk about the combination of Misys Healthcare and Allscripts to
create a leader in US...
Misys and Allscripts Create a Leader in Healthcare Software
18th March 2008 LONDON, March 18 /PRNewswire/ -- In a video interview Mike Lawrie, CEO Misys, and Glen Tullman, CEO
Allscripts, talk about the combination of Misys Healthcare and Allscripts to
create a leader in...
Spize TV Partners Pyramid Saimira
14th March 2008 LONDON, March 14 /PRNewswire/ --
- Launches DTH Services Across Europe, North Africa & Middle East